Atlas FDA

WRAPSODY Cell-Impermeable Endoprosthesis

FDA premarket approval P240023/S002 · decided 2025-02-12

Approval details

PMA number
P240023
Supplement
S002
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Postapproval Study Protocol
Trade name
WRAPSODY Cell-Impermeable Endoprosthesis
Generic name
System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatment
Applicant
Merit Medical Systems, Inc.
Date received
2025-01-15
Decision date
2025-02-12
Days to decision
28 days
Decision code
APPR
Product code
PFV
Advisory committee
Cardiovascular
Expedited review
No
Location
South Jordan, UT
Statement
approval of the protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240023.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
FlexTract Deflectable-Rotational Dilator Sheath Set (K261310)Merit Medical Systems, Inc.2026-07-27
PreludeSYNC™ Radial Compression Device (K262086)Merit Medical Systems, Inc.2026-07-22
StatSeal Disc (K254073)Merit Medical Systems, Inc.2026-05-13
STAR RF Ablation System (K251802)Merit Medical Systems, Inc.2026-02-13
SCOUT MD Surgical Guidance System (K252892)Merit Medical Systems, Inc.2025-12-19
Merit Syringe (K250853)Merit Medical Systems, Inc.2025-11-04
Resilience Fully Covered Esophageal Stent System (K251265)Merit Medical Systems, Inc.2025-07-23
Prelude Wave Hydrophilic Sheath Introducer (K250909)Merit Medical Systems, Inc.2025-04-25